Medicine price: quote on request. Your total cost is quoted in writing per case.
We give you a written timeline estimate for your case before you commit.
Ask about Poherdy

Is Poherdy available in Pakistan? Status, route and cost

A plain answer for families in Pakistan, checked against FDA, regulator and manufacturer sources on 17 October 2026.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Is Poherdy available in Pakistan?

We have not checked Poherdy's registration with DRAP, Pakistan's regulator, so ask the treating hospital to confirm it. Poherdy is a biosimilar to Perjeta for HER2-positive breast cancer, given by infusion. When a doctor prescribes a medicine not registered in Pakistan, DRAP can issue a no objection certificate for personal-use import.

  • Registration: Not checked by us; ask the treating hospital to confirm it with DRAP.
  • Access route: Personal-use import permission from DRAP, on a doctor's prescription.
  • Who acts: the patient or a blood relative applies to DRAP for a personal-use NOC, with the prescription of a registered medical practitioner; a hospital can instead apply for an institutional NOC.
  • Timeline: We give you a written timeline estimate for your case before you commit.
  • Price: Medicine price: quote on request. You get a written quote for your case before you commit.

Status, with dates

  • The FDA announced Poherdy's approval on 13 November 2025, as the first biosimilar to Perjeta and interchangeable with it. (source)
  • DRAP issues a no objection certificate (NOC) for personal-use import, and a separate NOC for hospitals and institutions that import unregistered medicines. (source)

What Poherdy is

Poherdy (pertuzumab-dpzb) is a biosimilar to Perjeta (pertuzumab). It is made by Shanghai Henlius Biotech and distributed in the US by Organon. The FDA announced its approval on 13 November 2025 as the first biosimilar to Perjeta, and also as interchangeable with Perjeta. In the US, interchangeable means a pharmacy may substitute it for Perjeta without contacting the prescriber, where state pharmacy law allows. Other countries set their own rules.

It is used together with trastuzumab and chemotherapy in adults with HER2-positive breast cancer: for metastatic breast cancer, with trastuzumab and docetaxel, when no anti-HER2 therapy or chemotherapy has been given for metastatic disease; before surgery (neoadjuvant) for locally advanced, inflammatory or early-stage breast cancer that is larger than 2 cm or has spread to lymph nodes; and after surgery (adjuvant) for early breast cancer at high risk of coming back.

How it is given and safety

It is given by intravenous infusion: a first dose of 840 mg over 60 minutes, then 420 mg every 3 weeks over 30 to 60 minutes. It comes as a 420 mg/14 mL single-dose vial that must be kept in a refrigerator at 2°C to 8°C, protected from light, and not frozen or shaken. Any shipment therefore needs a cold chain.

The US label has a boxed warning. Pertuzumab products can weaken the heart's pumping (a fall in LVEF, or heart failure), so heart function is checked before and during treatment. Exposure during pregnancy can cause the loss of the baby or birth defects. Other serious risks are infusion reactions and allergic reactions. Common side effects include diarrhea, hair loss, low white blood cell counts, nausea and tiredness.

How access works in Pakistan

In Pakistan, the Drug Regulatory Authority of Pakistan (DRAP) issues a no objection certificate (NOC) for importing a medicine for personal use. The Government of Pakistan said in February 2018 that when a registered medical practitioner prescribes a medicine that is not registered in Pakistan, the patient can import it for personal use with DRAP's permission.

DRAP's checklist asks for a request to the Assistant Director (Import and Export) at DRAP, preferably from the patient or a blood relative; copies of the CNIC or passport of the applicant and the patient; contact numbers for both; and a prescription on the letterhead of a registered medical practitioner, signed and stamped. DRAP says personal-use applications are made on its online portal.

DRAP also issues NOCs to hospitals and institutions that import unregistered medicines. They apply at the nearest DRAP field office with the documents on DRAP's checklist. Narcotic, psychotropic and controlled medicines need extra approval from DRAP's Controlled Drugs Division.

We have not checked this medicine against DRAP's register. Ask your doctor or hospital to confirm its current status in Pakistan before anything is filed, and confirm the current NOC procedure with DRAP.

Who does what

  • Your treating doctor decides whether Poherdy is right for the patient and writes the prescription the application needs.
  • The patient or family applies to DRAP with the documents below, unless a hospital applies for an institutional permission instead.
  • The Drug Regulatory Authority of Pakistan (DRAP) decides whether to permit the import, and how much.
  • The hospital or clinic gives the infusion and monitors the patient.
  • Reserve Meds helps you prepare the file, and where the import is permitted, arranges US supply through our licensed wholesale partner. We do not give medical advice.

Documents you will usually need

  • The pathology report confirming HER2-positive breast cancer, with the stage
  • A recent heart function result (LVEF), because the label requires a heart check before treatment
  • The oncologist's treatment plan, including the trastuzumab and chemotherapy that will be given with it
  • Identity documents for the patient (and the applicant, if different), as the regulator asks
  • The prescription from a registered medical practitioner, with the doctor's registration number, the medicine, the quantity and the duration

Steps

  1. Prescription. Your doctor writes the prescription and a short clinical summary for Poherdy.
  2. Application. The patient or family sends the application and documents to DRAP.
  3. Permission. DRAP reviews the file and issues its permission, or asks for more information.
  4. US sourcing. Our US-licensed wholesale partner supplies the medicine, shipped refrigerated at 2°C to 8°C.
  5. Treatment. The hospital gives the infusion and checks heart function as the label requires.

Timeline and cost

We give you a written timeline estimate for your case before you commit. The regulator, the hospital and the manufacturer set their own timelines.

Medicine price: quote on request. You get a written quote for your case before you commit. Your total cost depends on the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We coordinate access to FDA-approved medicines only. We help your family understand the route, organize records and communication with the doctor and hospital, and, where an import is approved, arrange US supply and refrigerated (2°C to 8°C) shipping through our licensed wholesale partner. Delivery follows the terms of the import approval and is confirmed in writing before you commit. We do not prescribe, and we do not decide what DRAP approves.

Ask about Poherdy in Pakistan

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Include the country code, for example +966, +971 or +91.
Message us on WhatsApp

No account needed. We reply within one business day. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Frequently asked questions

Is Poherdy registered in Pakistan?

We have not checked this medicine against DRAP's register. Ask your doctor or hospital to confirm its current status in Pakistan before anything is filed, and confirm the current NOC procedure with DRAP.

How do patients in Pakistan get Poherdy?

In Pakistan, the Drug Regulatory Authority of Pakistan (DRAP) issues a no objection certificate (NOC) for importing a medicine for personal use. The Government of Pakistan said in February 2018 that when a registered medical practitioner prescribes a medicine that is not registered in Pakistan, the patient can import it for personal use with DRAP's permission. DRAP's checklist asks for a request to the Assistant Director (Import and Export) at DRAP, preferably from the patient or a blood relative; copies of the CNIC or passport of the applicant and the patient; contact numbers for both; and a prescription on the letterhead of a registered medical practitioner, signed and stamped. DRAP says personal-use applications are made on its online portal.

How long does it take to get Poherdy in Pakistan?

We give you a written timeline estimate for your case before you commit. The regulator, the hospital and the manufacturer set their own timelines, and we tell you honestly what depends on them.

How much does Poherdy cost?

Medicine price: quote on request. You get a written quote for your case before you commit. Your total cost, including shipping, import steps and coordination, is quoted in writing before you commit. No hidden charges.

Is Poherdy the same as Perjeta?

Poherdy is a biosimilar to Perjeta, approved by the FDA as interchangeable with it in the US. Both contain pertuzumab and have the same uses on the US label. Whether one can replace the other in your country is decided by the local regulator and your oncologist.

Sources

Checked on 17 October 2026. Regulator rules and lists change. Your doctor, hospital pharmacy or the regulator confirms the current position before anything is filed.

  1. FDA: FDA approves first interchangeable biosimilar to Perjeta to treat certain types of breast cancer (13 Nov 2025)
  2. Organon: POHERDY (pertuzumab-dpzb) US prescribing information, revised 11/2025
  3. Henlius and Organon announce US FDA approval of POHERDY (Business Wire, 17 Nov 2025)
  4. DRAP Pakistan: Special permissions (NOC for personal-use import; NOC for hospitals and institutions importing unregistered medicines)
  5. DRAP Pakistan: Checklist for application of import of medicine for personal use
  6. Press Information Department, Government of Pakistan: DRAP allows patients to import medicines for personal use (PR No. 184, 24 Feb 2018)

Related

WhatsApp